Using bumetanide to treat autism appears promising but further clinical trials are needed to confirm this approach
Acta Paediatr
.
2021 May;110(5):1395-1397.
doi: 10.1111/apa.15747.
Epub 2021 Jan 23.
Authors
Yehezkel Ben-Ari
1
,
Eric Lemonnier
2
Affiliations
1
Neurochlore and Ben-Ari Institute of Neuroarcheology (IBEN), Marseille, France.
2
CHU Limoges, Limoges, France.
PMID:
33484191
DOI:
10.1111/apa.15747
No abstract available
Publication types
Editorial
Comment
MeSH terms
Autistic Disorder* / drug therapy
Bumetanide* / therapeutic use
Child
Humans
Substances
Bumetanide